{"transactions":[{"id":687859,"issuer":{"id":5349,"kind":"organization","name":"Altimmune, Inc.","symbol":"ALT"},"owners":[{"id":23679,"kind":"person","name":"Durso Jerome Benedict","position":1,"cik":"0001698665","reported_name":"Durso Jerome Benedict","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Common Stock, par value $0.0001","published_at":"2026-08-13T20:05:06.000Z","date":"2026-08-13","kind":"purchase","planned":false,"acquired":true,"shares":15000,"price":2.95,"value":44250.0,"ownership":{"direct":true},"balance_after":62500,"source":{"system":"sec-edgar","filing":"0001698665-26-000007","document":"form4-08132026_040801.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1326190/000169866526000007/form4-08132026_040801.xml","form_type":"4"}},{"id":822737,"issuer":{"id":5349,"kind":"organization","name":"Altimmune, Inc.","symbol":"ALT"},"owners":[{"id":23679,"kind":"person","name":"Durso Jerome Benedict","position":1,"cik":"0001698665","reported_name":"Durso Jerome Benedict","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Common Stock, par value $0.0001","published_at":"2026-04-01T20:05:14.000Z","date":"2026-04-01","kind":"purchase","planned":false,"acquired":true,"shares":15000,"price":3.14,"value":47100.0,"ownership":{"direct":true},"balance_after":47500,"source":{"system":"sec-edgar","filing":"0001698665-26-000005","document":"form4-04012026_040404.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1326190/000169866526000005/form4-04012026_040404.xml","form_type":"4"}},{"id":853336,"issuer":{"id":5349,"kind":"organization","name":"Altimmune, Inc.","symbol":"ALT"},"owners":[{"id":23679,"kind":"person","name":"Durso Jerome Benedict","position":1,"cik":"0001698665","reported_name":"Durso Jerome Benedict","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Common Stock, par value $0.0001","published_at":"2026-03-09T11:00:05.000Z","date":"2026-03-06","kind":"purchase","planned":false,"acquired":true,"shares":20000,"price":3.5395,"value":70790.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $3.5300 to $3.5500, inclusive. The reporting person undertakes to provide to Altimmune, Inc., any security holder of Altimmune, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the ranges set forth in this footnote."}],"balance_after":32500,"source":{"system":"sec-edgar","filing":"0001698665-26-000003","document":"form4-03092026_070301.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1326190/000169866526000003/form4-03092026_070301.xml","form_type":"4"}},{"id":960809,"issuer":{"id":5349,"kind":"organization","name":"Altimmune, Inc.","symbol":"ALT"},"owners":[{"id":23679,"kind":"person","name":"Durso Jerome Benedict","position":1,"cik":"0001698665","reported_name":"Durso Jerome Benedict","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock, par value $0.0001","published_at":"2025-12-22T21:10:38.000Z","date":"2025-12-22","kind":"purchase","planned":false,"acquired":true,"shares":12500,"price":4.1255,"value":51568.75,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $4.1200 to $4.1300, inclusive. The reporting person undertakes to provide to Altimmune, Inc., any security holder of Altimmune, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the ranges set forth in this footnote"}],"balance_after":12500,"source":{"system":"sec-edgar","filing":"0001698665-25-000005","document":"form4-12222025_091234.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1326190/000169866525000005/form4-12222025_091234.xml","form_type":"4"}},{"id":984969,"issuer":{"id":5349,"kind":"organization","name":"Altimmune, Inc.","symbol":"ALT"},"owners":[{"id":23679,"kind":"person","name":"Durso Jerome Benedict","position":1,"cik":"0001698665","reported_name":"Durso Jerome Benedict","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CEO-elect"}}],"security":"Restricted Stock Units","published_at":"2025-12-02T01:38:33.000Z","date":"2025-12-01","kind":"grant","planned":false,"acquired":true,"shares":633700,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F2","text":"Each Restricted Stock Unit (\"RSU\") represents a contingent right to receive one share of Common Stock, par value $0.0001, when vested."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"The RSUs become vested over four (4) years with 25% of the shares vesting December 1, 2026, with the remainder vesting in equal annual installments for the following three (3) years, subject to the reporting person's continued service through the applicable vesting date, and have no expiration date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F3","text":"The RSUs become vested over four (4) years with 25% of the shares vesting December 1, 2026, with the remainder vesting in equal annual installments for the following three (3) years, subject to the reporting person's continued service through the applicable vesting date, and have no expiration date."}],"balance_after":633700,"derivative":{"underlying":"Common Stock, par value $0.0001","underlying_shares":633700},"source":{"system":"sec-edgar","filing":"0001104659-25-117451","document":"tm2532516-1_4seq1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1326190/000110465925117451/tm2532516-1_4seq1.xml","form_type":"4"}},{"id":984968,"issuer":{"id":5349,"kind":"organization","name":"Altimmune, Inc.","symbol":"ALT"},"owners":[{"id":23679,"kind":"person","name":"Durso Jerome Benedict","position":1,"cik":"0001698665","reported_name":"Durso Jerome Benedict","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CEO-elect"}}],"security":"Stock Options (option to buy)","published_at":"2025-12-02T01:38:33.000Z","date":"2025-12-01","kind":"grant","planned":false,"acquired":true,"shares":1824400,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The shares underlying the option become vested and exercisable over four (4) years with 25% of the shares vesting on December 1, 2026, with the remainder vesting in equal monthly installments for the following thirty-six (36) months, subject to the reporting person's continued service on each applicable vesting date."}],"balance_after":1824400,"derivative":{"exercise_price":4.93,"expiration_date":"2035-12-01","underlying":"Common Stock, par value $0.0001","underlying_shares":1824400},"source":{"system":"sec-edgar","filing":"0001104659-25-117451","document":"tm2532516-1_4seq1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1326190/000110465925117451/tm2532516-1_4seq1.xml","form_type":"4"}},{"id":1031148,"issuer":{"id":5349,"kind":"organization","name":"Altimmune, Inc.","symbol":"ALT"},"owners":[{"id":23679,"kind":"person","name":"Durso Jerome Benedict","position":1,"cik":"0001698665","reported_name":"Durso Jerome Benedict","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Options (option to buy)","published_at":"2025-09-29T20:20:03.000Z","date":"2025-09-25","kind":"grant","planned":false,"acquired":true,"shares":48800,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The shares underlying the option become vested and exercisable in substantially equal monthly installments over the 12 months following September 25, 2025, subject to the reporting person's continued service through the applicable vesting date."}],"balance_after":48800,"derivative":{"exercise_price":3.92,"expiration_date":"2035-09-25","underlying":"Common Stock, par value $0.0001","underlying_shares":48800},"source":{"system":"sec-edgar","filing":"0001104659-25-094499","document":"tm2527377-8_4seq1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1326190/000110465925094499/tm2527377-8_4seq1.xml","form_type":"4"}},{"id":1245767,"issuer":{"id":5349,"kind":"organization","name":"Altimmune, Inc.","symbol":"ALT"},"owners":[{"id":23679,"kind":"person","name":"Durso Jerome Benedict","position":1,"cik":"0001698665","reported_name":"Durso Jerome Benedict","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Options (option to buy)","published_at":"2025-02-25T22:46:09.000Z","date":"2025-02-24","kind":"grant","planned":false,"acquired":true,"shares":69800,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The shares underlying the option become vested and exercisable in 36 substantially equal monthly installments following February 24, 2025 subject to the reporting person's continued service through the applicable vesting date."}],"balance_after":69800,"derivative":{"exercise_price":6.11,"expiration_date":"2035-02-24","underlying":"Common Stock, par value $0.0001","underlying_shares":69800},"source":{"system":"sec-edgar","filing":"0001104659-25-017006","document":"tm257585-3_4seq1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1326190/000110465925017006/tm257585-3_4seq1.xml","form_type":"4"}},{"id":1743572,"issuer":{"id":108343,"kind":"organization","name":"INTERCEPT PHARMACEUTICALS, INC.","symbol":"ICPT"},"owners":[{"id":23679,"kind":"person","name":"Durso Jerome Benedict","position":1,"cik":"0001698665","reported_name":"Durso Jerome Benedict","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CEO"}}],"security":"Option to Purchase Common Stock","published_at":"2023-11-13T14:40:48.000Z","date":"2023-11-08","kind":"disposition_to_issuer","planned":false,"acquired":false,"shares":72000,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F5","text":"Pursuant to the Merger Agreement, each option to purchase shares of Company Common Stock that was outstanding and unexercised as of immediately prior to the Effective Time, whether or not vested, with a per share exercise price that was equal to or greater than the Offer Price was cancelled with no consideration payable in respect thereof."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F5","text":"Pursuant to the Merger Agreement, each option to purchase shares of Company Common Stock that was outstanding and unexercised as of immediately prior to the Effective Time, whether or not vested, with a per share exercise price that was equal to or greater than the Offer Price was cancelled with no consideration payable in respect thereof."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F5","text":"Pursuant to the Merger Agreement, each option to purchase shares of Company Common Stock that was outstanding and unexercised as of immediately prior to the Effective Time, whether or not vested, with a per share exercise price that was equal to or greater than the Offer Price was cancelled with no consideration payable in respect thereof."}],"balance_after":0,"derivative":{"exercise_price":29.46,"underlying":"Common Stock","underlying_shares":72000},"source":{"system":"sec-edgar","filing":"0001104659-23-117096","document":"tm2330435-7_4seq1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":12,"url":"https://www.sec.gov/Archives/edgar/data/1270073/000110465923117096/tm2330435-7_4seq1.xml","form_type":"4"}},{"id":1743571,"issuer":{"id":108343,"kind":"organization","name":"INTERCEPT PHARMACEUTICALS, INC.","symbol":"ICPT"},"owners":[{"id":23679,"kind":"person","name":"Durso Jerome Benedict","position":1,"cik":"0001698665","reported_name":"Durso Jerome Benedict","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CEO"}}],"security":"Option to Purchase Common Stock","published_at":"2023-11-13T14:40:48.000Z","date":"2023-11-08","kind":"disposition_to_issuer","planned":false,"acquired":false,"shares":17400,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F5","text":"Pursuant to the Merger Agreement, each option to purchase shares of Company Common Stock that was outstanding and unexercised as of immediately prior to the Effective Time, whether or not vested, with a per share exercise price that was equal to or greater than the Offer Price was cancelled with no consideration payable in respect thereof."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F5","text":"Pursuant to the Merger Agreement, each option to purchase shares of Company Common Stock that was outstanding and unexercised as of immediately prior to the Effective Time, whether or not vested, with a per share exercise price that was equal to or greater than the Offer Price was cancelled with no consideration payable in respect thereof."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F5","text":"Pursuant to the Merger Agreement, each option to purchase shares of Company Common Stock that was outstanding and unexercised as of immediately prior to the Effective Time, whether or not vested, with a per share exercise price that was equal to or greater than the Offer Price was cancelled with no consideration payable in respect thereof."}],"balance_after":0,"derivative":{"exercise_price":99.66,"underlying":"Common Stock","underlying_shares":17400},"source":{"system":"sec-edgar","filing":"0001104659-23-117096","document":"tm2330435-7_4seq1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":11,"url":"https://www.sec.gov/Archives/edgar/data/1270073/000110465923117096/tm2330435-7_4seq1.xml","form_type":"4"}},{"id":1743570,"issuer":{"id":108343,"kind":"organization","name":"INTERCEPT PHARMACEUTICALS, INC.","symbol":"ICPT"},"owners":[{"id":23679,"kind":"person","name":"Durso Jerome Benedict","position":1,"cik":"0001698665","reported_name":"Durso Jerome Benedict","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CEO"}}],"security":"Option to Purchase Common Stock","published_at":"2023-11-13T14:40:48.000Z","date":"2023-11-08","kind":"disposition_to_issuer","planned":false,"acquired":false,"shares":14304,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F5","text":"Pursuant to the Merger Agreement, each option to purchase shares of Company Common Stock that was outstanding and unexercised as of immediately prior to the Effective Time, whether or not vested, with a per share exercise price that was equal to or greater than the Offer Price was cancelled with no consideration payable in respect thereof."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F5","text":"Pursuant to the Merger Agreement, each option to purchase shares of Company Common Stock that was outstanding and unexercised as of immediately prior to the Effective Time, whether or not vested, with a per share exercise price that was equal to or greater than the Offer Price was cancelled with no consideration payable in respect thereof."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F5","text":"Pursuant to the Merger Agreement, each option to purchase shares of Company Common Stock that was outstanding and unexercised as of immediately prior to the Effective Time, whether or not vested, with a per share exercise price that was equal to or greater than the Offer Price was cancelled with no consideration payable in respect thereof."}],"balance_after":0,"derivative":{"exercise_price":110.8,"underlying":"Common Stock","underlying_shares":14304},"source":{"system":"sec-edgar","filing":"0001104659-23-117096","document":"tm2330435-7_4seq1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":10,"url":"https://www.sec.gov/Archives/edgar/data/1270073/000110465923117096/tm2330435-7_4seq1.xml","form_type":"4"}},{"id":1743569,"issuer":{"id":108343,"kind":"organization","name":"INTERCEPT PHARMACEUTICALS, INC.","symbol":"ICPT"},"owners":[{"id":23679,"kind":"person","name":"Durso Jerome Benedict","position":1,"cik":"0001698665","reported_name":"Durso Jerome Benedict","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CEO"}}],"security":"Option to Purchase Common Stock","published_at":"2023-11-13T14:40:48.000Z","date":"2023-11-08","kind":"disposition_to_issuer","planned":false,"acquired":false,"shares":896,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F5","text":"Pursuant to the Merger Agreement, each option to purchase shares of Company Common Stock that was outstanding and unexercised as of immediately prior to the Effective Time, whether or not vested, with a per share exercise price that was equal to or greater than the Offer Price was cancelled with no consideration payable in respect thereof."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F5","text":"Pursuant to the Merger Agreement, each option to purchase shares of Company Common Stock that was outstanding and unexercised as of immediately prior to the Effective Time, whether or not vested, with a per share exercise price that was equal to or greater than the Offer Price was cancelled with no consideration payable in respect thereof."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F5","text":"Pursuant to the Merger Agreement, each option to purchase shares of Company Common Stock that was outstanding and unexercised as of immediately prior to the Effective Time, whether or not vested, with a per share exercise price that was equal to or greater than the Offer Price was cancelled with no consideration payable in respect thereof."}],"balance_after":0,"derivative":{"exercise_price":110.8,"underlying":"Common Stock","underlying_shares":896},"source":{"system":"sec-edgar","filing":"0001104659-23-117096","document":"tm2330435-7_4seq1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":9,"url":"https://www.sec.gov/Archives/edgar/data/1270073/000110465923117096/tm2330435-7_4seq1.xml","form_type":"4"}},{"id":1743568,"issuer":{"id":108343,"kind":"organization","name":"INTERCEPT PHARMACEUTICALS, INC.","symbol":"ICPT"},"owners":[{"id":23679,"kind":"person","name":"Durso Jerome Benedict","position":1,"cik":"0001698665","reported_name":"Durso Jerome Benedict","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CEO"}}],"security":"Option to Purchase Common Stock","published_at":"2023-11-13T14:40:48.000Z","date":"2023-11-08","kind":"disposition_to_issuer","planned":false,"acquired":false,"shares":20629,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F5","text":"Pursuant to the Merger Agreement, each option to purchase shares of Company Common Stock that was outstanding and unexercised as of immediately prior to the Effective Time, whether or not vested, with a per share exercise price that was equal to or greater than the Offer Price was cancelled with no consideration payable in respect thereof."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F5","text":"Pursuant to the Merger Agreement, each option to purchase shares of Company Common Stock that was outstanding and unexercised as of immediately prior to the Effective Time, whether or not vested, with a per share exercise price that was equal to or greater than the Offer Price was cancelled with no consideration payable in respect thereof."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F5","text":"Pursuant to the Merger Agreement, each option to purchase shares of Company Common Stock that was outstanding and unexercised as of immediately prior to the Effective Time, whether or not vested, with a per share exercise price that was equal to or greater than the Offer Price was cancelled with no consideration payable in respect thereof."}],"balance_after":0,"derivative":{"exercise_price":58.74,"underlying":"Common Stock","underlying_shares":20629},"source":{"system":"sec-edgar","filing":"0001104659-23-117096","document":"tm2330435-7_4seq1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":8,"url":"https://www.sec.gov/Archives/edgar/data/1270073/000110465923117096/tm2330435-7_4seq1.xml","form_type":"4"}},{"id":1743567,"issuer":{"id":108343,"kind":"organization","name":"INTERCEPT PHARMACEUTICALS, INC.","symbol":"ICPT"},"owners":[{"id":23679,"kind":"person","name":"Durso Jerome Benedict","position":1,"cik":"0001698665","reported_name":"Durso Jerome Benedict","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CEO"}}],"security":"Option to Purchase Common Stock","published_at":"2023-11-13T14:40:48.000Z","date":"2023-11-08","kind":"disposition_to_issuer","planned":false,"acquired":false,"shares":71,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F5","text":"Pursuant to the Merger Agreement, each option to purchase shares of Company Common Stock that was outstanding and unexercised as of immediately prior to the Effective Time, whether or not vested, with a per share exercise price that was equal to or greater than the Offer Price was cancelled with no consideration payable in respect thereof."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F5","text":"Pursuant to the Merger Agreement, each option to purchase shares of Company Common Stock that was outstanding and unexercised as of immediately prior to the Effective Time, whether or not vested, with a per share exercise price that was equal to or greater than the Offer Price was cancelled with no consideration payable in respect thereof."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F5","text":"Pursuant to the Merger Agreement, each option to purchase shares of Company Common Stock that was outstanding and unexercised as of immediately prior to the Effective Time, whether or not vested, with a per share exercise price that was equal to or greater than the Offer Price was cancelled with no consideration payable in respect thereof."}],"balance_after":0,"derivative":{"exercise_price":58.74,"underlying":"Common Stock","underlying_shares":71},"source":{"system":"sec-edgar","filing":"0001104659-23-117096","document":"tm2330435-7_4seq1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":7,"url":"https://www.sec.gov/Archives/edgar/data/1270073/000110465923117096/tm2330435-7_4seq1.xml","form_type":"4"}},{"id":1743566,"issuer":{"id":108343,"kind":"organization","name":"INTERCEPT PHARMACEUTICALS, INC.","symbol":"ICPT"},"owners":[{"id":23679,"kind":"person","name":"Durso Jerome Benedict","position":1,"cik":"0001698665","reported_name":"Durso Jerome Benedict","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CEO"}}],"security":"Option to Purchase Common Stock","published_at":"2023-11-13T14:40:48.000Z","date":"2023-11-08","kind":"disposition_to_issuer","planned":false,"acquired":false,"shares":16581,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F5","text":"Pursuant to the Merger Agreement, each option to purchase shares of Company Common Stock that was outstanding and unexercised as of immediately prior to the Effective Time, whether or not vested, with a per share exercise price that was equal to or greater than the Offer Price was cancelled with no consideration payable in respect thereof."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F5","text":"Pursuant to the Merger Agreement, each option to purchase shares of Company Common Stock that was outstanding and unexercised as of immediately prior to the Effective Time, whether or not vested, with a per share exercise price that was equal to or greater than the Offer Price was cancelled with no consideration payable in respect thereof."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F5","text":"Pursuant to the Merger Agreement, each option to purchase shares of Company Common Stock that was outstanding and unexercised as of immediately prior to the Effective Time, whether or not vested, with a per share exercise price that was equal to or greater than the Offer Price was cancelled with no consideration payable in respect thereof."}],"balance_after":0,"derivative":{"exercise_price":115.93,"underlying":"Common Stock","underlying_shares":16581},"source":{"system":"sec-edgar","filing":"0001104659-23-117096","document":"tm2330435-7_4seq1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/1270073/000110465923117096/tm2330435-7_4seq1.xml","form_type":"4"}},{"id":1743565,"issuer":{"id":108343,"kind":"organization","name":"INTERCEPT PHARMACEUTICALS, INC.","symbol":"ICPT"},"owners":[{"id":23679,"kind":"person","name":"Durso Jerome Benedict","position":1,"cik":"0001698665","reported_name":"Durso Jerome Benedict","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CEO"}}],"security":"Option to Purchase Common Stock","published_at":"2023-11-13T14:40:48.000Z","date":"2023-11-08","kind":"disposition_to_issuer","planned":false,"acquired":false,"shares":3419,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F5","text":"Pursuant to the Merger Agreement, each option to purchase shares of Company Common Stock that was outstanding and unexercised as of immediately prior to the Effective Time, whether or not vested, with a per share exercise price that was equal to or greater than the Offer Price was cancelled with no consideration payable in respect thereof."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F5","text":"Pursuant to the Merger Agreement, each option to purchase shares of Company Common Stock that was outstanding and unexercised as of immediately prior to the Effective Time, whether or not vested, with a per share exercise price that was equal to or greater than the Offer Price was cancelled with no consideration payable in respect thereof."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F5","text":"Pursuant to the Merger Agreement, each option to purchase shares of Company Common Stock that was outstanding and unexercised as of immediately prior to the Effective Time, whether or not vested, with a per share exercise price that was equal to or greater than the Offer Price was cancelled with no consideration payable in respect thereof."}],"balance_after":0,"derivative":{"exercise_price":115.93,"underlying":"Common Stock","underlying_shares":3419},"source":{"system":"sec-edgar","filing":"0001104659-23-117096","document":"tm2330435-7_4seq1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1270073/000110465923117096/tm2330435-7_4seq1.xml","form_type":"4"}},{"id":1743564,"issuer":{"id":108343,"kind":"organization","name":"INTERCEPT PHARMACEUTICALS, INC.","symbol":"ICPT"},"owners":[{"id":23679,"kind":"person","name":"Durso Jerome Benedict","position":1,"cik":"0001698665","reported_name":"Durso Jerome Benedict","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CEO"}}],"security":"Option to Purchase Common Stock","published_at":"2023-11-13T14:40:48.000Z","date":"2023-11-08","kind":"disposition_to_issuer","planned":false,"acquired":false,"shares":82700,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F4","text":"Pursuant to the Merger Agreement, each option to purchase shares of Company Common Stock that was outstanding and unexercised as of immediately prior to the Effective Time, whether or not vested, with a per share exercise price that was less than the Offer Price, was cancelled and converted into the right to receive a cash payment (without interest, and less any applicable withholding taxes) equal to (A) the excess of (x) the Offer Price over (y) the exercise price payable per share of Company Common Stock under such option, multiplied by (B) the total number of shares of Company Common Stock subject to such option immediately prior to the Effective Time."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"Pursuant to the Merger Agreement, each option to purchase shares of Company Common Stock that was outstanding and unexercised as of immediately prior to the Effective Time, whether or not vested, with a per share exercise price that was less than the Offer Price, was cancelled and converted into the right to receive a cash payment (without interest, and less any applicable withholding taxes) equal to (A) the excess of (x) the Offer Price over (y) the exercise price payable per share of Company Common Stock under such option, multiplied by (B) the total number of shares of Company Common Stock subject to such option immediately prior to the Effective Time."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F4","text":"Pursuant to the Merger Agreement, each option to purchase shares of Company Common Stock that was outstanding and unexercised as of immediately prior to the Effective Time, whether or not vested, with a per share exercise price that was less than the Offer Price, was cancelled and converted into the right to receive a cash payment (without interest, and less any applicable withholding taxes) equal to (A) the excess of (x) the Offer Price over (y) the exercise price payable per share of Company Common Stock under such option, multiplied by (B) the total number of shares of Company Common Stock subject to such option immediately prior to the Effective Time."}],"balance_after":0,"derivative":{"exercise_price":18.4,"underlying":"Common Stock","underlying_shares":82700},"source":{"system":"sec-edgar","filing":"0001104659-23-117096","document":"tm2330435-7_4seq1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1270073/000110465923117096/tm2330435-7_4seq1.xml","form_type":"4"}},{"id":1743563,"issuer":{"id":108343,"kind":"organization","name":"INTERCEPT PHARMACEUTICALS, INC.","symbol":"ICPT"},"owners":[{"id":23679,"kind":"person","name":"Durso Jerome Benedict","position":1,"cik":"0001698665","reported_name":"Durso Jerome Benedict","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CEO"}}],"security":"Option to Purchase Common Stock","published_at":"2023-11-13T14:40:48.000Z","date":"2023-11-08","kind":"disposition_to_issuer","planned":false,"acquired":false,"shares":60900,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F4","text":"Pursuant to the Merger Agreement, each option to purchase shares of Company Common Stock that was outstanding and unexercised as of immediately prior to the Effective Time, whether or not vested, with a per share exercise price that was less than the Offer Price, was cancelled and converted into the right to receive a cash payment (without interest, and less any applicable withholding taxes) equal to (A) the excess of (x) the Offer Price over (y) the exercise price payable per share of Company Common Stock under such option, multiplied by (B) the total number of shares of Company Common Stock subject to such option immediately prior to the Effective Time."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"Pursuant to the Merger Agreement, each option to purchase shares of Company Common Stock that was outstanding and unexercised as of immediately prior to the Effective Time, whether or not vested, with a per share exercise price that was less than the Offer Price, was cancelled and converted into the right to receive a cash payment (without interest, and less any applicable withholding taxes) equal to (A) the excess of (x) the Offer Price over (y) the exercise price payable per share of Company Common Stock under such option, multiplied by (B) the total number of shares of Company Common Stock subject to such option immediately prior to the Effective Time."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F4","text":"Pursuant to the Merger Agreement, each option to purchase shares of Company Common Stock that was outstanding and unexercised as of immediately prior to the Effective Time, whether or not vested, with a per share exercise price that was less than the Offer Price, was cancelled and converted into the right to receive a cash payment (without interest, and less any applicable withholding taxes) equal to (A) the excess of (x) the Offer Price over (y) the exercise price payable per share of Company Common Stock under such option, multiplied by (B) the total number of shares of Company Common Stock subject to such option immediately prior to the Effective Time."}],"balance_after":0,"derivative":{"exercise_price":14.44,"underlying":"Common Stock","underlying_shares":60900},"source":{"system":"sec-edgar","filing":"0001104659-23-117096","document":"tm2330435-7_4seq1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1270073/000110465923117096/tm2330435-7_4seq1.xml","form_type":"4"}},{"id":1743562,"issuer":{"id":108343,"kind":"organization","name":"INTERCEPT PHARMACEUTICALS, INC.","symbol":"ICPT"},"owners":[{"id":23679,"kind":"person","name":"Durso Jerome Benedict","position":1,"cik":"0001698665","reported_name":"Durso Jerome Benedict","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CEO"}}],"security":"Common Stock","published_at":"2023-11-13T14:40:48.000Z","date":"2023-11-08","kind":"disposition_to_issuer","planned":false,"acquired":false,"shares":102825,"price":19,"value":1953675.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F2","text":"Represents restricted stock units (\"RSUs\") granted to the Reporting Person. Each RSU represented a contingent right to receive one share of Company Common Stock upon vesting of the RSU."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"Pursuant to the Merger Agreement, at the Effective Time, each RSU that was outstanding as of immediately prior to the Effective Time was cancelled and converted into the contingent right to receive a cash payment (without interest and subject to any applicable tax withholding) equal to (A) the Offer Price, multiplied by (B) the number of shares of Company Common Stock subject to such RSU. Such payment right will vest and become payable in accordance with vesting schedule (including any vesting acceleration provisions) that applied to the corresponding portion of the applicable RSUs immediately prior to the Effective Time."}],"balance_after":0,"source":{"system":"sec-edgar","filing":"0001104659-23-117096","document":"tm2330435-7_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1270073/000110465923117096/tm2330435-7_4seq1.xml","form_type":"4"}},{"id":1743561,"issuer":{"id":108343,"kind":"organization","name":"INTERCEPT PHARMACEUTICALS, INC.","symbol":"ICPT"},"owners":[{"id":23679,"kind":"person","name":"Durso Jerome Benedict","position":1,"cik":"0001698665","reported_name":"Durso Jerome Benedict","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CEO"}}],"security":"Common Stock","published_at":"2023-11-13T14:40:48.000Z","date":"2023-11-08","kind":"other","planned":false,"acquired":false,"shares":51815,"price":19,"value":984485.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"This Form 4 reports securities disposed of pursuant to the terms of the Agreement and Plan of Merger (the \"Merger Agreement\"), dated as of September 26, 2023, among the Issuer, Alfasigma S.p.A. (\"Alfasigma\"), and Interstellar Acquisition Inc., a wholly owned subsidiary of Alfasigma (\"Purchaser\"), pursuant to which Purchaser completed a tender offer for shares of common stock of the Issuer (\"Company Common Stock\") and thereafter merged with and into the Issuer, effective as of November 8, 2023 (the \"Effective Time\"). At the Effective Time, each issued and outstanding share of Company Common Stock was cancelled and converted into the right to receive $19.00 in cash (the \"Offer Price\") without interest and subject to applicable withholding taxes."}],"balance_after":0,"source":{"system":"sec-edgar","filing":"0001104659-23-117096","document":"tm2330435-7_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1270073/000110465923117096/tm2330435-7_4seq1.xml","form_type":"4"}},{"id":2040116,"issuer":{"id":108343,"kind":"organization","name":"INTERCEPT PHARMACEUTICALS, INC.","symbol":"ICPT"},"owners":[{"id":23679,"kind":"person","name":"Durso Jerome Benedict","position":1,"cik":"0001698665","reported_name":"Durso Jerome Benedict","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President & CEO"}}],"security":"Option to Purchase Common Stock","published_at":"2023-01-31T16:04:08.000Z","date":"2023-01-27","kind":"grant","acquired":true,"shares":82700,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The award shall be subject to a four-year vesting period, with 25% of the shares subject to the award vesting and becoming exercisable in an initial annual installment following the Vesting Commencement Date and 1/48th of the shares subject to the award vesting and becoming exercisable each month thereafter. The Vesting Commencement Date is January 1, 2023."}],"balance_after":82700,"derivative":{"exercise_price":18.4,"expiration_date":"2033-01-27","underlying":"Common Stock","underlying_shares":82700},"source":{"system":"sec-edgar","filing":"0001104659-23-008582","document":"tm234878-2_4seq1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1270073/000110465923008582/tm234878-2_4seq1.xml","form_type":"4"}},{"id":2040115,"issuer":{"id":108343,"kind":"organization","name":"INTERCEPT PHARMACEUTICALS, INC.","symbol":"ICPT"},"owners":[{"id":23679,"kind":"person","name":"Durso Jerome Benedict","position":1,"cik":"0001698665","reported_name":"Durso Jerome Benedict","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President & CEO"}}],"security":"Common Stock","published_at":"2023-01-31T16:04:08.000Z","date":"2023-01-27","kind":"grant","acquired":true,"shares":50400,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents restricted stock units granted to the Reporting Person. Each restricted stock unit represents a contingent right to receive one share of the Issuer's Common Stock. The award shall be subject to a four-year vesting period, with the shares subject to the award vesting in four equal annual installments following the Vesting Commencement Date. The Vesting Commencement Date is January 1, 2023."}],"balance_after":154640,"source":{"system":"sec-edgar","filing":"0001104659-23-008582","document":"tm234878-2_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1270073/000110465923008582/tm234878-2_4seq1.xml","form_type":"4"}},{"id":2072347,"issuer":{"id":108343,"kind":"organization","name":"INTERCEPT PHARMACEUTICALS, INC.","symbol":"ICPT"},"owners":[{"id":23679,"kind":"person","name":"Durso Jerome Benedict","position":1,"cik":"0001698665","reported_name":"Durso Jerome Benedict","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President & CEO"}}],"security":"Common Stock","published_at":"2023-01-03T16:01:47.000Z","date":"2022-12-31","kind":"tax_withholding","acquired":false,"shares":7083,"price":12.37,"value":87616.71,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents shares of common stock withheld by the Issuer to satisfy taxes associated with the partial vesting of restricted stock unit awards previously granted to the reporting person."}],"balance_after":104240,"source":{"system":"sec-edgar","filing":"0001104659-23-000329","document":"tm231319-2_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1270073/000110465923000329/tm231319-2_4seq1.xml","form_type":"4"}},{"id":2420993,"issuer":{"id":108343,"kind":"organization","name":"INTERCEPT PHARMACEUTICALS, INC.","symbol":"ICPT"},"owners":[{"id":23679,"kind":"person","name":"Durso Jerome Benedict","position":1,"cik":"0001698665","reported_name":"Durso Jerome Benedict","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President & CEO"}}],"security":"Option to Purchase Common Stock","published_at":"2022-01-31T16:14:27.000Z","date":"2022-01-27","kind":"grant","acquired":true,"shares":60900,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The award shall be subject to a four-year vesting period, with 25% of the shares subject to the award vesting and becoming exercisable in an initial annual installment following the Vesting Commencement Date and 1/48th of the shares subject to the award vesting and becoming exercisable each month thereafter. The Vesting Commencement Date is January 1, 2022."}],"balance_after":60900,"derivative":{"exercise_price":14.44,"expiration_date":"2032-01-27","underlying":"Common Stock","underlying_shares":60900},"source":{"system":"sec-edgar","filing":"0001104659-22-009555","document":"tm224882-4_4seq1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1270073/000110465922009555/tm224882-4_4seq1.xml","form_type":"4"}},{"id":2420992,"issuer":{"id":108343,"kind":"organization","name":"INTERCEPT PHARMACEUTICALS, INC.","symbol":"ICPT"},"owners":[{"id":23679,"kind":"person","name":"Durso Jerome Benedict","position":1,"cik":"0001698665","reported_name":"Durso Jerome Benedict","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President & CEO"}}],"security":"Common Stock","published_at":"2022-01-31T16:14:27.000Z","date":"2022-01-27","kind":"grant","acquired":true,"shares":35700,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents restricted stock units granted to the Reporting Person. Each restricted stock unit represents a contingent right to receive one share of the Issuer's Common Stock. The award shall be subject to a four-year vesting period, with the shares subject to the award vesting in four equal annual installments following the Vesting Commencement Date. The Vesting Commencement Date is January 1, 2022."}],"balance_after":111323,"source":{"system":"sec-edgar","filing":"0001104659-22-009555","document":"tm224882-4_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1270073/000110465922009555/tm224882-4_4seq1.xml","form_type":"4"}},{"id":2448242,"issuer":{"id":108343,"kind":"organization","name":"INTERCEPT PHARMACEUTICALS, INC.","symbol":"ICPT"},"owners":[{"id":23679,"kind":"person","name":"Durso Jerome Benedict","position":1,"cik":"0001698665","reported_name":"Durso Jerome Benedict","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President & CEO"}}],"security":"Common Stock","published_at":"2022-01-04T16:16:14.000Z","date":"2022-01-01","kind":"tax_withholding","acquired":false,"shares":334,"price":16.29,"value":5440.86,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents shares of common stock withheld by the Issuer to satisfy taxes associated with the partial vesting of restricted stock unit awards previously granted to the reporting person."}],"balance_after":75623,"source":{"system":"sec-edgar","filing":"0001104659-22-000917","document":"tm221409d2_4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1270073/000110465922000917/tm221409d2_4.xml","form_type":"4"}},{"id":2448241,"issuer":{"id":108343,"kind":"organization","name":"INTERCEPT PHARMACEUTICALS, INC.","symbol":"ICPT"},"owners":[{"id":23679,"kind":"person","name":"Durso Jerome Benedict","position":1,"cik":"0001698665","reported_name":"Durso Jerome Benedict","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President & CEO"}}],"security":"Common Stock","published_at":"2022-01-04T16:16:14.000Z","date":"2021-12-31","kind":"tax_withholding","acquired":false,"shares":5607,"price":16.29,"value":91338.03,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents shares of common stock withheld by the Issuer to satisfy taxes associated with the partial vesting of restricted stock unit awards previously granted to the reporting person."}],"balance_after":75957,"source":{"system":"sec-edgar","filing":"0001104659-22-000917","document":"tm221409d2_4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1270073/000110465922000917/tm221409d2_4.xml","form_type":"4"}},{"id":2548468,"issuer":{"id":108343,"kind":"organization","name":"INTERCEPT PHARMACEUTICALS, INC.","symbol":"ICPT"},"owners":[{"id":23679,"kind":"person","name":"Durso Jerome Benedict","position":1,"cik":"0001698665","reported_name":"Durso Jerome Benedict","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President & CEO"}}],"security":"Common Stock","published_at":"2021-10-05T17:28:09.000Z","date":"2021-10-01","kind":"tax_withholding","acquired":false,"shares":289,"price":15.22,"value":4398.58,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents shares of common stock withheld by the Issuer to satisfy taxes associated with the partial vesting of a restricted stock unit award previously granted to the reporting person."}],"balance_after":81564,"source":{"system":"sec-edgar","filing":"0001104659-21-123209","document":"tm2129255d1_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1270073/000110465921123209/tm2129255d1_4seq1.xml","form_type":"4"}},{"id":2644092,"issuer":{"id":108343,"kind":"organization","name":"INTERCEPT PHARMACEUTICALS, INC.","symbol":"ICPT"},"owners":[{"id":23679,"kind":"person","name":"Durso Jerome Benedict","position":1,"cik":"0001698665","reported_name":"Durso Jerome Benedict","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President & CEO"}}],"security":"Common Stock","published_at":"2021-07-02T19:00:52.000Z","date":"2021-07-01","kind":"tax_withholding","acquired":false,"shares":289,"price":20.47,"value":5915.83,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents shares of common stock withheld by the Issuer to satisfy taxes associated with the partial vesting of a restricted stock unit award previously granted to the reporting person."}],"balance_after":81853,"source":{"system":"sec-edgar","filing":"0001104659-21-089031","document":"tm2121399-1_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1270073/000110465921089031/tm2121399-1_4seq1.xml","form_type":"4"}},{"id":2757344,"issuer":{"id":108343,"kind":"organization","name":"INTERCEPT PHARMACEUTICALS, INC.","symbol":"ICPT"},"owners":[{"id":23679,"kind":"person","name":"Durso Jerome Benedict","position":1,"cik":"0001698665","reported_name":"Durso Jerome Benedict","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President & CEO"}}],"security":"Common Stock","published_at":"2021-04-05T19:02:27.000Z","date":"2021-04-01","kind":"tax_withholding","acquired":false,"shares":289,"price":24.28,"value":7016.92,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents shares of common stock withheld by the Issuer to satisfy taxes associated with the partial vesting of a restricted stock unit award previously granted to the reporting person."}],"balance_after":82142,"source":{"system":"sec-edgar","filing":"0001104659-21-046699","document":"tm2111402-3_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1270073/000110465921046699/tm2111402-3_4seq1.xml","form_type":"4"}},{"id":2832299,"issuer":{"id":108343,"kind":"organization","name":"INTERCEPT PHARMACEUTICALS, INC.","symbol":"ICPT"},"owners":[{"id":23679,"kind":"person","name":"Durso Jerome Benedict","position":1,"cik":"0001698665","reported_name":"Durso Jerome Benedict","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President & CEO"}}],"security":"Common Stock","published_at":"2021-02-25T19:01:04.000Z","date":"2021-02-23","kind":"tax_withholding","acquired":false,"shares":319,"price":28.12,"value":8970.28,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents shares of common stock withheld by the Issuer to satisfy taxes associated with the partial vesting of a restricted stock award previously granted to the reporting person."}],"balance_after":82431,"source":{"system":"sec-edgar","filing":"0001104659-21-028419","document":"tm218010-1_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1270073/000110465921028419/tm218010-1_4seq1.xml","form_type":"4"}},{"id":2895001,"issuer":{"id":108343,"kind":"organization","name":"INTERCEPT PHARMACEUTICALS, INC.","symbol":"ICPT"},"owners":[{"id":23679,"kind":"person","name":"Durso Jerome Benedict","position":1,"cik":"0001698665","reported_name":"Durso Jerome Benedict","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President & CEO"}}],"security":"Option to Purchase Common Stock","published_at":"2021-01-26T19:01:01.000Z","date":"2021-01-22","kind":"grant","acquired":true,"shares":72000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The award shall be subject to a four-year vesting period, with 25% of the shares subject to the award vesting and becoming exercisable in an initial annual installment following the Vesting Commencement Date and 1/48th of the shares subject to the award vesting and becoming exercisable each month thereafter. The Vesting Commencement Date is January 1, 2021."}],"balance_after":72000,"derivative":{"exercise_price":29.46,"expiration_date":"2031-01-22","underlying":"Common Stock","underlying_shares":72000},"source":{"system":"sec-edgar","filing":"0001104659-21-007777","document":"tm214232-2_4seq1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1270073/000110465921007777/tm214232-2_4seq1.xml","form_type":"4"}},{"id":2895000,"issuer":{"id":108343,"kind":"organization","name":"INTERCEPT PHARMACEUTICALS, INC.","symbol":"ICPT"},"owners":[{"id":23679,"kind":"person","name":"Durso Jerome Benedict","position":1,"cik":"0001698665","reported_name":"Durso Jerome Benedict","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President & CEO"}}],"security":"Common Stock","published_at":"2021-01-26T19:01:01.000Z","date":"2021-01-22","kind":"grant","acquired":true,"shares":46000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents restricted stock units granted to the Reporting Person. Each restricted stock unit represents a contingent right to receive one share of the Issuer's Common Stock. The award shall be subject to a four-year vesting period, with the shares subject to the award vesting in four equal annual installments following the Vesting Commencement Date. The Vesting Commencement Date is January 1, 2021."}],"balance_after":82750,"source":{"system":"sec-edgar","filing":"0001104659-21-007777","document":"tm214232-2_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1270073/000110465921007777/tm214232-2_4seq1.xml","form_type":"4"}},{"id":2919918,"issuer":{"id":108343,"kind":"organization","name":"INTERCEPT PHARMACEUTICALS, INC.","symbol":"ICPT"},"owners":[{"id":23679,"kind":"person","name":"Durso Jerome Benedict","position":1,"cik":"0001698665","reported_name":"Durso Jerome Benedict","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President & CEO"}}],"security":"Common Stock","published_at":"2021-01-05T19:00:39.000Z","date":"2021-01-01","kind":"tax_withholding","acquired":false,"shares":334,"price":24.7,"value":8249.8,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents shares of common stock withheld by the Issuer to satisfy taxes associated with the partial vesting of restricted stock unit awards previously granted to the reporting person."}],"balance_after":36750,"source":{"system":"sec-edgar","filing":"0001104659-21-001120","document":"tm211606-2_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1270073/000110465921001120/tm211606-2_4seq1.xml","form_type":"4"}},{"id":2919917,"issuer":{"id":108343,"kind":"organization","name":"INTERCEPT PHARMACEUTICALS, INC.","symbol":"ICPT"},"owners":[{"id":23679,"kind":"person","name":"Durso Jerome Benedict","position":1,"cik":"0001698665","reported_name":"Durso Jerome Benedict","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President & CEO"}}],"security":"Common Stock","published_at":"2021-01-05T19:00:39.000Z","date":"2020-12-31","kind":"tax_withholding","acquired":false,"shares":1700,"price":24.7,"value":41990.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents shares of common stock withheld by the Issuer to satisfy taxes associated with the partial vesting of restricted stock unit awards previously granted to the reporting person."}],"balance_after":37084,"source":{"system":"sec-edgar","filing":"0001104659-21-001120","document":"tm211606-2_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1270073/000110465921001120/tm211606-2_4seq1.xml","form_type":"4"}},{"id":2965966,"issuer":{"id":108343,"kind":"organization","name":"INTERCEPT PHARMACEUTICALS, INC.","symbol":"ICPT"},"owners":[{"id":23679,"kind":"person","name":"Durso Jerome Benedict","position":1,"cik":"0001698665","reported_name":"Durso Jerome Benedict","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Operating Officer"}}],"security":"Common Stock","published_at":"2020-11-25T19:00:18.000Z","date":"2020-11-23","kind":"tax_withholding","acquired":false,"shares":319,"price":35.47,"value":11314.93,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents shares of common stock withheld by the Issuer to satisfy taxes associated with the partial vesting of a restricted stock award previously granted to the reporting person."}],"balance_after":38784,"source":{"system":"sec-edgar","filing":"0001104659-20-129687","document":"tm2037136-1_4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1270073/000110465920129687/tm2037136-1_4.xml","form_type":"4"}},{"id":3012872,"issuer":{"id":108343,"kind":"organization","name":"INTERCEPT PHARMACEUTICALS, INC.","symbol":"ICPT"},"owners":[{"id":23679,"kind":"person","name":"Durso Jerome Benedict","position":1,"cik":"0001698665","reported_name":"Durso Jerome Benedict","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Operating Officer"}}],"security":"Common Stock","published_at":"2020-10-05T19:02:05.000Z","date":"2020-10-01","kind":"tax_withholding","acquired":false,"shares":289,"price":42.08,"value":12161.12,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents shares of common stock withheld by the Issuer to satisfy taxes associated with the partial vesting of a restricted stock unit award previously granted to the reporting person."}],"balance_after":39103,"source":{"system":"sec-edgar","filing":"0001104659-20-112321","document":"tm2032461d6_4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1270073/000110465920112321/tm2032461d6_4.xml","form_type":"4"}},{"id":3047484,"issuer":{"id":108343,"kind":"organization","name":"INTERCEPT PHARMACEUTICALS, INC.","symbol":"ICPT"},"owners":[{"id":23679,"kind":"person","name":"Durso Jerome Benedict","position":1,"cik":"0001698665","reported_name":"Durso Jerome Benedict","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Operating Officer"}}],"security":"Common Stock","published_at":"2020-08-25T19:00:24.000Z","date":"2020-08-23","kind":"tax_withholding","acquired":false,"shares":319,"price":48.21,"value":15378.99,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents shares of common stock withheld by the Issuer to satisfy taxes associated with the partial vesting of a restricted stock award previously granted to the reporting person."}],"balance_after":39392,"source":{"system":"sec-edgar","filing":"0001104659-20-098460","document":"tm2029378d1_4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1270073/000110465920098460/tm2029378d1_4.xml","form_type":"4"}},{"id":3088508,"issuer":{"id":108343,"kind":"organization","name":"INTERCEPT PHARMACEUTICALS, INC.","symbol":"ICPT"},"owners":[{"id":23679,"kind":"person","name":"Durso Jerome Benedict","position":1,"cik":"0001698665","reported_name":"Durso Jerome Benedict","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Operating Officer"}}],"security":"Common Stock","published_at":"2020-07-06T19:00:17.000Z","date":"2020-07-01","kind":"tax_withholding","acquired":false,"shares":289,"price":46.52,"value":13444.28,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents shares of common stock withheld by the Issuer to satisfy taxes associated with the partial vesting of a restricted stock unit award previously granted to the reporting person."}],"balance_after":39711,"source":{"system":"sec-edgar","filing":"0001104659-20-081430","document":"tm2024073d1_4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1270073/000110465920081430/tm2024073d1_4.xml","form_type":"4"}},{"id":3133435,"issuer":{"id":108343,"kind":"organization","name":"INTERCEPT PHARMACEUTICALS, INC.","symbol":"ICPT"},"owners":[{"id":23679,"kind":"person","name":"Durso Jerome Benedict","position":1,"cik":"0001698665","reported_name":"Durso Jerome Benedict","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Operating Officer"}}],"security":"Common Stock","published_at":"2020-05-27T19:00:26.000Z","date":"2020-05-23","kind":"tax_withholding","acquired":false,"shares":319,"price":80.51,"value":25682.69,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents shares of common stock withheld by the Issuer to satisfy taxes associated with the partial vesting of a restricted stock award previously granted to the reporting person."}],"balance_after":40000,"source":{"system":"sec-edgar","filing":"0001104659-20-066534","document":"tm2020981d1_4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1270073/000110465920066534/tm2020981d1_4.xml","form_type":"4"}},{"id":3182784,"issuer":{"id":108343,"kind":"organization","name":"INTERCEPT PHARMACEUTICALS, INC.","symbol":"ICPT"},"owners":[{"id":23679,"kind":"person","name":"Durso Jerome Benedict","position":1,"cik":"0001698665","reported_name":"Durso Jerome Benedict","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Operating Officer"}}],"security":"Common Stock","published_at":"2020-04-03T19:02:31.000Z","date":"2020-04-01","kind":"tax_withholding","acquired":false,"shares":289,"price":58.4,"value":16877.6,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents shares of common stock withheld by the Issuer to satisfy taxes associated with the partial vesting of a restricted stock unit award previously granted to the reporting person."}],"balance_after":40319,"source":{"system":"sec-edgar","filing":"0001104659-20-043285","document":"tm2014981d3_4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1270073/000110465920043285/tm2014981d3_4.xml","form_type":"4"}},{"id":3252621,"issuer":{"id":108343,"kind":"organization","name":"INTERCEPT PHARMACEUTICALS, INC.","symbol":"ICPT"},"owners":[{"id":23679,"kind":"person","name":"Durso Jerome Benedict","position":1,"cik":"0001698665","reported_name":"Durso Jerome Benedict","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Operating Officer"}}],"security":"Common Stock","published_at":"2020-02-24T19:00:24.000Z","date":"2020-02-23","kind":"tax_withholding","acquired":false,"shares":319,"price":94.99,"value":30301.81,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents shares of common stock withheld by the Issuer to satisfy taxes associated with the partial vesting of a restricted stock award previously granted to the reporting person."}],"balance_after":40608,"source":{"system":"sec-edgar","filing":"0001104659-20-024371","document":"tm2010776d1_4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1270073/000110465920024371/tm2010776d1_4.xml","form_type":"4"}},{"id":3301190,"issuer":{"id":108343,"kind":"organization","name":"INTERCEPT PHARMACEUTICALS, INC.","symbol":"ICPT"},"owners":[{"id":23679,"kind":"person","name":"Durso Jerome Benedict","position":1,"cik":"0001698665","reported_name":"Durso Jerome Benedict","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Operating Officer"}}],"security":"Option to Purchase Common Stock","published_at":"2020-01-27T19:05:05.000Z","date":"2020-01-23","kind":"grant","acquired":true,"shares":17400,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The award shall be subject to a four-year vesting period, with 25% of the shares subject to the award vesting and becoming exercisable in an initial annual installment following the Vesting Commencement Date and 1/48th of the shares subject to the award vesting and becoming exercisable each month thereafter. The Vesting Commencement Date is January 1, 2020."}],"balance_after":17400,"derivative":{"exercise_price":99.66,"expiration_date":"2030-01-23","underlying":"Common Stock","underlying_shares":17400},"source":{"system":"sec-edgar","filing":"0001104659-20-007264","document":"tm205922d5_4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1270073/000110465920007264/tm205922d5_4.xml","form_type":"4"}},{"id":3301189,"issuer":{"id":108343,"kind":"organization","name":"INTERCEPT PHARMACEUTICALS, INC.","symbol":"ICPT"},"owners":[{"id":23679,"kind":"person","name":"Durso Jerome Benedict","position":1,"cik":"0001698665","reported_name":"Durso Jerome Benedict","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Operating Officer"}}],"security":"Common Stock","published_at":"2020-01-27T19:05:05.000Z","date":"2020-01-23","kind":"grant","acquired":true,"shares":10600,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents restricted stock units granted to the Reporting Person. Each restricted stock unit represents a contingent right to receive one share of the Issuer's Common Stock. The award shall be subject to a four-year vesting period, with the shares subject to the award vesting in four equal annual installments following the Vesting Commencement Date. The Vesting Commencement Date is January 1, 2020."}],"balance_after":40927,"source":{"system":"sec-edgar","filing":"0001104659-20-007264","document":"tm205922d5_4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1270073/000110465920007264/tm205922d5_4.xml","form_type":"4"}},{"id":3322333,"issuer":{"id":108343,"kind":"organization","name":"INTERCEPT PHARMACEUTICALS, INC.","symbol":"ICPT"},"owners":[{"id":23679,"kind":"person","name":"Durso Jerome Benedict","position":1,"cik":"0001698665","reported_name":"Durso Jerome Benedict","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Operating Officer"}}],"security":"Common Stock","published_at":"2020-01-03T19:00:54.000Z","date":"2020-01-01","kind":"tax_withholding","acquired":false,"shares":334,"price":123.92,"value":41389.28,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents shares of common stock withheld by the Issuer to satisfy taxes associated with the partial vesting of a restricted stock unit award previously granted to the reporting person."}],"balance_after":30327,"source":{"system":"sec-edgar","filing":"0001104659-20-001090","document":"tm201209d7_4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1270073/000110465920001090/tm201209d7_4.xml","form_type":"4"}},{"id":3322332,"issuer":{"id":108343,"kind":"organization","name":"INTERCEPT PHARMACEUTICALS, INC.","symbol":"ICPT"},"owners":[{"id":23679,"kind":"person","name":"Durso Jerome Benedict","position":1,"cik":"0001698665","reported_name":"Durso Jerome Benedict","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Operating Officer"}}],"security":"Common Stock","published_at":"2020-01-03T19:00:54.000Z","date":"2019-12-31","kind":"tax_withholding","acquired":false,"shares":1151,"price":123.92,"value":142631.92,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents shares of common stock withheld by the Issuer to satisfy taxes associated with the partial vesting of a restricted stock unit award previously granted to the reporting person."}],"balance_after":30661,"source":{"system":"sec-edgar","filing":"0001104659-20-001090","document":"tm201209d7_4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1270073/000110465920001090/tm201209d7_4.xml","form_type":"4"}},{"id":3358590,"issuer":{"id":108343,"kind":"organization","name":"INTERCEPT PHARMACEUTICALS, INC.","symbol":"ICPT"},"owners":[{"id":23679,"kind":"person","name":"Durso Jerome Benedict","position":1,"cik":"0001698665","reported_name":"Durso Jerome Benedict","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Operating Officer"}}],"security":"Common Stock","published_at":"2019-11-26T19:00:38.000Z","date":"2019-11-23","kind":"tax_withholding","acquired":false,"shares":460,"price":88.89,"value":40889.4,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents shares of common stock withheld by the Issuer to satisfy taxes associated with the partial vesting of a restricted stock award previously granted to the reporting person."}],"balance_after":31812,"source":{"system":"sec-edgar","filing":"0001104659-19-067741","document":"tm1923933d1_4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1270073/000110465919067741/tm1923933d1_4.xml","form_type":"4"}},{"id":3398296,"issuer":{"id":108343,"kind":"organization","name":"INTERCEPT PHARMACEUTICALS, INC.","symbol":"ICPT"},"owners":[{"id":23679,"kind":"person","name":"Durso Jerome Benedict","position":1,"cik":"0001698665","reported_name":"Durso Jerome Benedict","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Operating Officer"}}],"security":"Common Stock","published_at":"2019-10-03T19:03:55.000Z","date":"2019-10-01","kind":"tax_withholding","acquired":false,"shares":417,"price":65.87,"value":27467.79,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents shares of common stock withheld by the Issuer to satisfy taxes associated with the partial vesting of a restricted stock unit award previously granted to the reporting person."}],"balance_after":32272,"source":{"system":"sec-edgar","filing":"0001144204-19-047224","document":"tv530564_4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1270073/000114420419047224/tv530564_4.xml","form_type":"4"}},{"id":3427974,"issuer":{"id":108343,"kind":"organization","name":"INTERCEPT PHARMACEUTICALS, INC.","symbol":"ICPT"},"owners":[{"id":23679,"kind":"person","name":"Durso Jerome Benedict","position":1,"cik":"0001698665","reported_name":"Durso Jerome Benedict","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Operating Officer"}}],"security":"Common Stock","published_at":"2019-08-27T19:00:22.000Z","date":"2019-08-23","kind":"tax_withholding","acquired":false,"shares":319,"price":60.9,"value":19427.1,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents shares of common stock withheld by the Issuer to satisfy taxes associated with the partial vesting of a restricted stock award previously granted to the reporting person."}],"balance_after":32689,"source":{"system":"sec-edgar","filing":"0001144204-19-041878","document":"tv528285_4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1270073/000114420419041878/tv528285_4.xml","form_type":"4"}},{"id":3467683,"issuer":{"id":108343,"kind":"organization","name":"INTERCEPT PHARMACEUTICALS, INC.","symbol":"ICPT"},"owners":[{"id":23679,"kind":"person","name":"Durso Jerome Benedict","position":1,"cik":"0001698665","reported_name":"Durso Jerome Benedict","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Operating Officer"}}],"security":"Common Stock","published_at":"2019-07-03T17:00:41.000Z","date":"2019-07-01","kind":"tax_withholding","acquired":false,"shares":289,"price":79.17,"value":22880.13,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents shares of common stock withheld by the Issuer to satisfy taxes associated with the partial vesting of a restricted stock unit award previously granted to the reporting person."}],"balance_after":33008,"source":{"system":"sec-edgar","filing":"0001144204-19-033814","document":"tv524733_form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1270073/000114420419033814/tv524733_form4.xml","form_type":"4"}},{"id":3510121,"issuer":{"id":108343,"kind":"organization","name":"INTERCEPT PHARMACEUTICALS, INC.","symbol":"ICPT"},"owners":[{"id":23679,"kind":"person","name":"Durso Jerome Benedict","position":1,"cik":"0001698665","reported_name":"Durso Jerome Benedict","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Operating Officer"}}],"security":"Common Stock","published_at":"2019-05-28T19:00:27.000Z","date":"2019-05-23","kind":"tax_withholding","acquired":false,"shares":460,"price":85.51,"value":39334.6,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents shares of common stock withheld by the Issuer to satisfy taxes associated with the partial vesting of a restricted stock award previously granted to the reporting person."}],"balance_after":33297,"source":{"system":"sec-edgar","filing":"0001144204-19-028491","document":"tv522437_4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1270073/000114420419028491/tv522437_4.xml","form_type":"4"}},{"id":3564260,"issuer":{"id":108343,"kind":"organization","name":"INTERCEPT PHARMACEUTICALS, INC.","symbol":"ICPT"},"owners":[{"id":23679,"kind":"person","name":"Durso Jerome Benedict","position":1,"cik":"0001698665","reported_name":"Durso Jerome Benedict","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Operating Officer"}}],"security":"Common Stock","published_at":"2019-04-03T19:01:33.000Z","date":"2019-04-01","kind":"tax_withholding","acquired":false,"shares":289,"price":111.5,"value":32223.5,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents shares of common stock withheld by the Issuer to satisfy taxes associated with the partial vesting of a restricted stock unit award previously granted to the reporting person."}],"balance_after":33757,"source":{"system":"sec-edgar","filing":"0001144204-19-018077","document":"tv517923_4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1270073/000114420419018077/tv517923_4.xml","form_type":"4"}},{"id":3631620,"issuer":{"id":108343,"kind":"organization","name":"INTERCEPT PHARMACEUTICALS, INC.","symbol":"ICPT"},"owners":[{"id":23679,"kind":"person","name":"Durso Jerome Benedict","position":1,"cik":"0001698665","reported_name":"Durso Jerome Benedict","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Operating Officer"}}],"security":"Common Stock","published_at":"2019-02-26T19:00:22.000Z","date":"2019-02-23","kind":"tax_withholding","acquired":false,"shares":319,"price":93.35,"value":29778.65,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents shares of common stock withheld by the Issuer to satisfy taxes associated with the partial vesting of a restricted stock award previously granted to the reporting person."}],"balance_after":34046,"source":{"system":"sec-edgar","filing":"0001144204-19-010308","document":"tv514617_4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1270073/000114420419010308/tv514617_4.xml","form_type":"4"}},{"id":3691682,"issuer":{"id":108343,"kind":"organization","name":"INTERCEPT PHARMACEUTICALS, INC.","symbol":"ICPT"},"owners":[{"id":23679,"kind":"person","name":"Durso Jerome Benedict","position":1,"cik":"0001698665","reported_name":"Durso Jerome Benedict","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Operating Officer"}}],"security":"Option to Purchase Common Stock","published_at":"2019-01-18T19:01:30.000Z","date":"2019-01-16","kind":"grant","acquired":true,"shares":15200,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The award shall be subject to a four-year vesting period, with 25% of the shares subject to the award vesting and becoming exercisable in an initial annual installment following the Vesting Commencement Date and 1/48th of the shares subject to the award vesting and becoming exercisable each month thereafter. The Vesting Commencement Date is January 1, 2019."}],"balance_after":15200,"derivative":{"exercise_price":110.8,"expiration_date":"2029-01-16","underlying":"Common Stock","underlying_shares":15200},"source":{"system":"sec-edgar","filing":"0001144204-19-002138","document":"tv511179_4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1270073/000114420419002138/tv511179_4.xml","form_type":"4"}},{"id":3691681,"issuer":{"id":108343,"kind":"organization","name":"INTERCEPT PHARMACEUTICALS, INC.","symbol":"ICPT"},"owners":[{"id":23679,"kind":"person","name":"Durso Jerome Benedict","position":1,"cik":"0001698665","reported_name":"Durso Jerome Benedict","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Operating Officer"}}],"security":"Common Stock","published_at":"2019-01-18T19:01:30.000Z","date":"2019-01-16","kind":"grant","acquired":true,"shares":9400,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents restricted stock units granted to the Reporting Person. Each restricted stock unit represents a contingent right to receive one share of the Issuer's Common Stock. The award shall be subject to a four-year vesting period, with the shares subject to the award vesting in four equal annual installments following the Vesting Commencement Date. The Vesting Commencement Date is January 1, 2019."}],"balance_after":34365,"source":{"system":"sec-edgar","filing":"0001144204-19-002138","document":"tv511179_4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1270073/000114420419002138/tv511179_4.xml","form_type":"4"}},{"id":3708145,"issuer":{"id":108343,"kind":"organization","name":"INTERCEPT PHARMACEUTICALS, INC.","symbol":"ICPT"},"owners":[{"id":23679,"kind":"person","name":"Durso Jerome Benedict","position":1,"cik":"0001698665","reported_name":"Durso Jerome Benedict","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Operating Officer"}}],"security":"Common Stock","published_at":"2019-01-03T19:01:41.000Z","date":"2019-01-01","kind":"tax_withholding","acquired":false,"shares":1219,"price":100.79,"value":122863.01,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents shares of common stock withheld to satisfy taxes associated with the vesting of restricted stock units."}],"balance_after":24965,"source":{"system":"sec-edgar","filing":"0001144204-19-000497","document":"tv510187_form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1270073/000114420419000497/tv510187_form4.xml","form_type":"4"}},{"id":3751691,"issuer":{"id":108343,"kind":"organization","name":"INTERCEPT PHARMACEUTICALS, INC.","symbol":"ICPT"},"owners":[{"id":23679,"kind":"person","name":"Durso Jerome Benedict","position":1,"cik":"0001698665","reported_name":"Durso Jerome Benedict","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Operating Officer"}}],"security":"Common Stock","published_at":"2018-11-27T19:01:16.000Z","date":"2018-11-23","kind":"tax_withholding","acquired":false,"shares":460,"price":111.07,"value":51092.2,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents shares of common stock withheld to satisfy taxes associated with the vesting of restricted stock."}],"balance_after":26184,"source":{"system":"sec-edgar","filing":"0001144204-18-061798","document":"tv507920_4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1270073/000114420418061798/tv507920_4.xml","form_type":"4"}},{"id":3798296,"issuer":{"id":108343,"kind":"organization","name":"INTERCEPT PHARMACEUTICALS, INC.","symbol":"ICPT"},"owners":[{"id":23679,"kind":"person","name":"Durso Jerome Benedict","position":1,"cik":"0001698665","reported_name":"Durso Jerome Benedict","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Operating Officer"}}],"security":"Common Stock","published_at":"2018-10-03T19:01:15.000Z","date":"2018-08-23","kind":"tax_withholding","acquired":false,"shares":319,"price":107.63,"value":34333.97,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents shares of common stock withheld to satisfy taxes associated with the vesting of restricted stock."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"In each case, the amount of securities beneficially owned following the reported transactions is provided as of the date of this Form 4."}],"balance_after":26644,"source":{"system":"sec-edgar","filing":"0001144204-18-052405","document":"tv503773_4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1270073/000114420418052405/tv503773_4.xml","form_type":"4"}},{"id":3798295,"issuer":{"id":108343,"kind":"organization","name":"INTERCEPT PHARMACEUTICALS, INC.","symbol":"ICPT"},"owners":[{"id":23679,"kind":"person","name":"Durso Jerome Benedict","position":1,"cik":"0001698665","reported_name":"Durso Jerome Benedict","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Operating Officer"}}],"security":"Common Stock","published_at":"2018-10-03T19:01:15.000Z","date":"2018-05-23","kind":"tax_withholding","acquired":false,"shares":319,"price":69.96,"value":22317.24,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents shares of common stock withheld to satisfy taxes associated with the vesting of restricted stock."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"In each case, the amount of securities beneficially owned following the reported transactions is provided as of the date of this Form 4."}],"balance_after":26644,"source":{"system":"sec-edgar","filing":"0001144204-18-052405","document":"tv503773_4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1270073/000114420418052405/tv503773_4.xml","form_type":"4"}},{"id":3798294,"issuer":{"id":108343,"kind":"organization","name":"INTERCEPT PHARMACEUTICALS, INC.","symbol":"ICPT"},"owners":[{"id":23679,"kind":"person","name":"Durso Jerome Benedict","position":1,"cik":"0001698665","reported_name":"Durso Jerome Benedict","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Operating Officer"}}],"security":"Common Stock","published_at":"2018-10-03T19:01:15.000Z","date":"2018-02-23","kind":"tax_withholding","acquired":false,"shares":1318,"price":62.04,"value":81768.72,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents shares of common stock withheld to satisfy taxes associated with the vesting of restricted stock."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"In each case, the amount of securities beneficially owned following the reported transactions is provided as of the date of this Form 4."}],"balance_after":26644,"source":{"system":"sec-edgar","filing":"0001144204-18-052405","document":"tv503773_4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1270073/000114420418052405/tv503773_4.xml","form_type":"4"}},{"id":4039916,"issuer":{"id":108343,"kind":"organization","name":"INTERCEPT PHARMACEUTICALS, INC.","symbol":"ICPT"},"owners":[{"id":23679,"kind":"person","name":"Durso Jerome Benedict","position":1,"cik":"0001698665","reported_name":"Durso Jerome Benedict","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Operating Officer"}}],"security":"Option to Purchase Common Stock","published_at":"2018-02-22T21:01:24.000Z","date":"2018-02-05","kind":"grant","acquired":true,"shares":20700,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"25% of the shares of common stock underlying this option will vest on January 1, 2019, subject to the terms and conditions of the award and the 2012 Plan. The remainder of the shares of common stock underlying this option will vest pro rata on a monthly basis after the initial vesting date through January 1, 2022 (representing the vesting on each such vesting date of approximately 2.0833% of the shares of common stock initially underlying this option), subject to the terms and conditions of the award and the 2012 Plan."}],"balance_after":20700,"derivative":{"exercise_price":58.74,"expiration_date":"2028-02-05","underlying":"Common Stock","underlying_shares":20700},"source":{"system":"sec-edgar","filing":"0001144204-18-010359","document":"tv486822_4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1270073/000114420418010359/tv486822_4.xml","form_type":"4"}},{"id":4039915,"issuer":{"id":108343,"kind":"organization","name":"INTERCEPT PHARMACEUTICALS, INC.","symbol":"ICPT"},"owners":[{"id":23679,"kind":"person","name":"Durso Jerome Benedict","position":1,"cik":"0001698665","reported_name":"Durso Jerome Benedict","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Operating Officer"}}],"security":"Common Stock","published_at":"2018-02-22T21:01:24.000Z","date":"2018-02-05","kind":"grant","acquired":true,"shares":13600,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents shares of common stock underlying restricted stock units (\"RSUs\") granted on February 5, 2018, with each RSU representing the contingent right to receive one share of common stock upon vesting of the RSU. 25% of the shares of common stock underlying these RSUs will vest on January 1, 2019, subject to the terms and conditions of the award and the Intercept Pharmaceuticals, Inc. 2012 Equity Incentive Plan (the \"2012 Plan\"). The remainder of the shares of common stock underlying the RSUs will vest pro rata on every subsequent three-month anniversary of the initial vesting date through January 1, 2022 (representing the vesting on each such vesting date of 6.25% of the shares of common stock initially underlying these RSUs), subject to the terms and conditions of the award and the 2012 Plan."}],"balance_after":28600,"source":{"system":"sec-edgar","filing":"0001144204-18-010359","document":"tv486822_4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1270073/000114420418010359/tv486822_4.xml","form_type":"4"}},{"id":4421105,"issuer":{"id":108343,"kind":"organization","name":"INTERCEPT PHARMACEUTICALS, INC.","symbol":"ICPT"},"owners":[{"id":23679,"kind":"person","name":"Durso Jerome Benedict","position":1,"cik":"0001698665","reported_name":"Durso Jerome Benedict","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Operating Officer"}}],"security":"Option to Purchase Common Stock","published_at":"2017-02-27T21:01:15.000Z","date":"2017-02-23","kind":"grant","acquired":true,"shares":20000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"25% of the shares of common stock underlying this option will vest on February 23, 2018, subject to the terms and conditions of the award and the 2012 Plan. The remainder of the shares of common stock underlying this option will vest pro rata on a monthly basis after the initial vesting date through February 23, 2021 (representing the vesting on each such vesting date of approximately 2.0833% of the shares of common stock initially underlying this option), subject to the terms and conditions of the award and the 2012 Plan."}],"balance_after":20000,"derivative":{"exercise_price":115.93,"expiration_date":"2027-02-23","underlying":"Common Stock","underlying_shares":20000},"source":{"system":"sec-edgar","filing":"0001144204-17-011478","document":"v460622_form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1270073/000114420417011478/v460622_form4.xml","form_type":"4"}},{"id":4421104,"issuer":{"id":108343,"kind":"organization","name":"INTERCEPT PHARMACEUTICALS, INC.","symbol":"ICPT"},"owners":[{"id":23679,"kind":"person","name":"Durso Jerome Benedict","position":1,"cik":"0001698665","reported_name":"Durso Jerome Benedict","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Operating Officer"}}],"security":"Common Stock","published_at":"2017-02-27T21:01:15.000Z","date":"2017-02-23","kind":"grant","acquired":true,"shares":15000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"25% of the shares of restricted stock will vest on February 23, 2018, subject to the terms and conditions of the award and the Intercept Pharmaceuticals, Inc. 2012 Equity Incentive Plan (the \"2012 Plan\"). The remaining shares of restricted stock will vest pro rata on every subsequent three-month anniversary of the initial vesting date through February 23, 2021 (representing the vesting on each such vesting date of 6.25% of the shares of restricted stock), subject to the terms and conditions of the award and the 2012 Plan."}],"balance_after":15000,"source":{"system":"sec-edgar","filing":"0001144204-17-011478","document":"v460622_form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1270073/000114420417011478/v460622_form4.xml","form_type":"4"}}]}